Novel 2,4-diaminoquinazoline derivatives are disclosed. The compounds can be used in treating diseases and conditions which are associated with abnormal cell function related to endoplasmic reticulum (ER) stress. For example, the compounds can be used as suppressors of ER stress-induced pancreatic β-cell dysfunction and death, for example in the treatment of diabetes.
本发明揭示了一种新型
2,4-二氨基喹唑啉衍
生物。这些化合物可用于治疗与内质网(ER)应激相关的异常细胞功能引起的疾病和病况。例如,这些化合物可用作抑制ER应激诱导的
胰岛素β细胞功能障碍和死亡的药物,例如用于治疗糖尿病。